The Latest Breaking News from AstraZeneca

Several pharmaceutical companies are racing to develop obesity drugs and tap into a surge in consumer demand for the extremely profitable drugs. Sales of Eli Lilly’s (LLY ) diabetes drug Mounjaro, just approved by the U.S. Food and Drug Administration (FDA) for obesity in the U.S., hit $1.41 billion in...

Only 20% of the top 1,000 companies have targets to reduce their emissions, a sign not enough leaders are taking climate change seriously.

A multi-million-pound landmark “vaccine damage” case is set to take place in London’s High Court. The test case is being pursued by Jamie Scott who suffered a severe brain injury in April 2021 after receiving the Oxford-AstraZeneca vaccine.

UK drugmaker signs agreement with China’s Eccogene to work on an obesity and type 2 diabetes pill

Shares in FTSE 100 heavyweight Diageo have tumbled after it cut guidance due to lower-than-expected demand in Latin America and the Caribbean.

AstraZeneca in partnership with the University of Oxford developed one of the first vaccines against COVID. The vaccine, which used an adenovirus to smuggle instructions into human cells to make antibodies against the novel coronavirus, saved countless lives. But a problem soon emerged. A tiny proportion – about one in…

Victorians have been warned to prepare for the possibility of thunderstorm asthma again this season.

A new shot for infants against RSV is in short supply, and U.S. health officials are telling doctors they should prioritize giving the drug to babies at the highest risk of severe disease

The Health and Social Care Committee heard from specialists in cancer research.

It is estimated that more than a million people in the UK are living with heart failure.

Among the highest paid CEOs were pharmaceutical giant AstraZeneca’s chief Pascal Soriot, with £15.3 million ($19.6 million), and defense company BAE Systems CEO Charles Woodburn, who earned £10.7 million ($13.7 million).